Amaechi, U. M., Deverapal, M., Oyebanji, O., Ntukidem, O. L., Okoye, C., Emeasoba, C. M., Michael, M. (2026). Real-world comparative outcomes of first-generation versus second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia: A global propensity-matched analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e18595